|
|
|
|
pmid:28958841
|
|
|
|
|
pmid:27663770
|
|
|
|
|
pmid:
|
Fang X et al. |
14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells. |
1998 |
Am. J. Physiol. |
pmid:9843811
|
Weintraub NL et al. |
Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids. |
1999 |
Am. J. Physiol. |
pmid:10564166
|
Campbell WB et al. |
14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels. |
2002 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:11959628
|
Gauthier KM et al. |
Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15528233
|
Fang X et al. |
14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha. |
2006 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:16113065
|
Fang X et al. |
Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels. |
2004 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15284062
|
Zheng C et al. |
Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats. |
2010 |
Am. J. Respir. Cell Mol. Biol. |
pmid:20118222
|